Curemarin™
Explore Curemarin, our conjugated estrogens vaginal cream.
Curemarin™ – Conjugated Estrogens Vaginal Cream
Curemarin is a conjugated estrogens vaginal cream formulated for local vaginal administration to support vaginal tissue health in estrogen-deficient conditions. It is designed to deliver conjugated estrogens directly at the site of application, helping restore vaginal physiology while minimizing systemic exposure.
Composition
Each gram of cream contains:
- Conjugated Estrogens IP
- Cream base q.s.
Indications
Curemarin is indicated for the management of symptoms associated with vaginal atrophy, including:
- Vaginal dryness
- Irritation
- Burning or discomfort
- Dyspareunia (as advised by a healthcare professional)
Mechanism of Action
Conjugated estrogens act locally on the vaginal epithelium to:
- Improve epithelial thickness
- Enhance lubrication
- Restore vaginal pH
- Support overall vaginal tissue integrity
Dosage & Administration
- To be used as directed by a registered medical practitioner
- Intended for vaginal use only
- Dosage and duration depend on individual clinical requirements
Safety Information
- For prescription use only
- Not intended for use without medical supervision
- Contraindicated in patients with known hypersensitivity to estrogens
- Refer to prescribing information for full safety details
Frequently asked questions
Here are some common questions about our product.
Curemarin is a conjugated vaginal cream used to manage symptoms associated with vaginal atrophy due to estrogen deficiency, such as dryness, irritation, and discomfort, as advised by a healthcare professional.
Curemarin delivers conjugated estrogens locally to the vaginal tissues, helping restore epithelial thickness, improve lubrication, and normalize vaginal pH.
Curemarin should be used only on the prescription of a registered medical practitioner, typically in women experiencing estrogen-deficient vaginal symptoms.
Curemarin is contraindicated in individuals with:
- Known hypersensitivity to estrogens
- Estrogen-dependent malignancies
-
Undiagnosed abnormal genital bleeding
(Refer to full prescribing information.)